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OBJECTIVE—The objective of the study was to determine the association between child BMI
at age 3 years and maternal glucose concentration among women without pre-existing diabetes
or a gestational diabetes mellitus (GDM) diagnosis.
RESEARCH DESIGN AND METHODS—Data are from the Pregnancy Infection and
Nutrition and Postpartum studies and include 263 mother-child pairs. Measured weights and
heights at 3 years were used to calculate age- and sex-speciﬁcB M Iz scores and percentiles.
Multivariable linear regression models were used to examine associations of continuous BMI
z scores with maternal glucose concentration. Modiﬁed Poisson regression estimated risk ratios
of child overweight/obesity (BMI $85th percentile).
RESULTS—Themean(SD)maternalglucoseconcentrationandprepregnancyBMIwere103.8
(23.7)mg/dLand24.3(5.9)kg/m
2,respectively.At3years,themean(SD)childBMIzscorewas
0.29 (0.99), 20.9% were overweight/obese and 5.3% were obese. In the adjusted model, when
comparedwithglucoseconcentration,100mg/dL,aconcentration$130mg/dLwasassociated
with signiﬁcantly higher child BMI z score at 3 years (estimated z s c o r ed i f f e r e n c eo f0 . 3 9[ 9 5 %
CI: 0.03–0.75]). With the use of the same reference category, a concentration $130 mg/dL was
associated with an approximate twofold greater risk of child overweight/obesity (adjusted risk
ratio 2.34 [95% CI: 1.25–4.38]).
CONCLUSIONS—Fetal exposure to high maternal glucose concentration in the absence of
pre-existing diabetes or GDM may contribute to the development of overweight/obesity in the
offspring, independent of maternal prepregnancy BMI.
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P
regnancies complicated by gesta-
tional diabetes mellitus (GDM) are
associated with several adverse out-
comes in the offspring including macro-
somia and the development of obesity
andtype2diabeteslaterinlife(1).Similar
observations for early infant outcomes
have been made for fetal exposure to
maternal hyperglycemia without a GDM
diagnosis.Inthemultinational,multicenter
Hyperglycemia and Adverse Pregnancy
Outcomes (HAPO)study,positiveassoci-
ations were found for high birth weight,
fetalhyperinsulinemia(measuredbycord
serumC-peptide),and neonatal adiposity
with increasing levels of maternal glucose
tolerance (2,3). Fewer studies are avail-
able for associations of offspring out-
comes later in life. Higher relative
weights in Pima Indian offspring at ages
5–24 years (4) and increased risk of child
obesity at 5–7 years in a multiethnic U.S.
population (5) were reported across in-
creasing levels of maternal glucose con-
centration; however, a recent analysis of
data from the Belfast, U.K. center of the
HAPO study found no association be-
tween maternal glucose and child obesity
at 2 years (6). Discrepancies in these ﬁnd-
ings may be due to differences in the study
populations, methodology, and/or ages
of the offspring at the time of outcome
assessment.
High maternal glucose concentration
during pregnancy is a modiﬁable and
preventable behavioral factor that may
represent an early life determinant of
pediatric obesity and its related comor-
bidities. The purpose of the current anal-
ysis was to determine the association
between child BMI at age 3 years and
maternal glucose concentration among
women without pre-existing diabetes or
a GDM diagnosis. Our results are inten-
ded to contribute to the limited amount of
literatureexaminingthis association, espe-
cially for offspring anthropometric out-
comes beyond the neonatal and infancy
periods. This research is useful to inform
prenatal intervention strategies, since there
is some evidence that treatment of hy-
perglycemiaduringpregnancyattenuates
adverse offspring outcomes such as mac-
rosomia (7) and possibly later childhood
obesity (5).
RESEARCH DESIGN AND
METHODS—Subjects were recruited
from the third cohort of the Pregnancy
Infection and Nutrition study (PIN), Jan-
uary 1, 2001 through June 30, 2005, and
followed through 3 years postpartum by
the PIN Postpartum (3 and 12 months
postpartum) and PIN Kids (3 years post-
partum) studies. The recruitment proto-
cols for the studies were documented
previously (8). Brieﬂy, pregnant women
who were at least 16 years of age at con-
ception, English speaking, before 20
weeks’ gestation at recruitment, and re-
ceiving prenatal care from public and pri-
vate clinics at the University of North
Carolina (UNC) Hospitals were eligible
forparticipation.ThePINstudyprotocols
were approved by the Institutional
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A total of 1,169 women in PIN
delivered a live singleton infant and
were eligible for recruitment into the
postpartum study. There were 689 and
550 mother-child pairs who participated
at 3 and 12 months postpartum, respec-
tively. The most common reasons for
nonparticipationincludedrefusal/request
to leave study (n = 202), unreachable/
moved out of study catchment area (n =
226),andineligibility(n=338)becauseof
medical constraints, timing issues, or
pregnancy. Recruitment for PIN Kids be-
g a ni n2 0 0 4a n da d d e da na s s e s s m e n to f
the index infant at 3 years. There were
409 mother-child pairs who completed
the 3-year visit. Three children were not
eligible for inclusion because a physician
diagnosedgrowth-relatedillness.Anthro-
pometric measurements were missing for
81 children, mostly because other data
were collected by phone interview rather
than home visit (n = 58) or the child was
unavailable, such as napping, during the
home interview. We further excluded
mothers with pre-existing diabetes (n =
20),GDM(n=9),ormissingglucosecon-
centration information (n = 3). Children
born before 37 weeks’ gestation (n = 30)
were also excluded. The remaining 263
mother-child pairs were included in the
current analyses.
Distributions of selected baseline
characteristics between eligible mother-
child pairs who participated in PIN Kids
(n = 406), PIN Postpartum (at 3 months
postpartum) pairs not included in PIN
Kids (n = 283), and eligible PIN pairs
not participating in PIN Postpartum
(n =480)wereexamined.Incomparison
withmothersinPINKids,thosenotpar-
ticipating in both PIN and PIN Postpar-
tum were signiﬁcantly younger and had
infants with lower mean birth weight
and gestational age. They were more
likely to be obese, black, unmarried,
less educated, and from low income
households. Additionally, a higher per-
centage of PIN Postpartum mothers not
participatinginPINKidssmokedduring
pregnancy. All other comparisons of
characteristics were not signiﬁcant.
There were no signiﬁcant differences
in the baseline characteristics of the
PIN Kids samples included (n = 263) in
this analysis and those excluded (n =
143) with the exception that excluded
women had a slightly higher prepreg-
nancy BMI (mean SD). BMI was 26.3
(7.8) kg/m
2 and 24.3 (5.9) kg/m
2 for
excluded and included women, respec-
tively (P =0 . 0 0 4 ) .
At the 3-year home visit, children’s
heights and weights were measured by
trained PIN staff using stadiometers and
scales,respectively, according to National
Health and Nutrition Examination Sur-
veys protocols (9). The mean (SD) age of
the children at the home visit was 3.04
(0.15) years. Child BMI at 3 years was
calculated from these measurements (in
kg/m
2) and converted to age- and sex-
speciﬁcB M Iz scores (continuous) and
percentiles (categories) using the 2000
Centers for Disease Control and Preven-
tion/National Center for Health Statistics
growth charts (10). Overweight/obesity
was deﬁned as BMI-for-age and sex $85th
percentile (reference ,85th percentile).
Maternal plasma glucose concentra-
tions were derived from universal screens
administered during the second trimester
(mean gestational age ;27 weeks) on all
women without pre-existing diabetes.
Theuniversalscreeninvolvedadministra-
tion of a random 1-h 50-g glucose chal-
lenge test (GCT) to the women. Women
with abnormal values on the GCT were
administered a 3-h oral glucose tolerance
test toconﬁrmGDMusingCarpenterand
Coustan criteria (11). For this analysis,
maternal plasma glucose concentrations
from the GCT were categorized using
the following cut points: ,100, 100–
,130, and $130 mg/dL. These cut
points are comparable with those used
inapreviousstudy (12),andglucosecon-
centrations$130mg/dLare suggestiveof
hyperglycemia (11).
MaternalprepregnancyBMI(inkg/m
2)
was calculated using self-reported pre-
pregnancy weight and measured height.
For quality assurance, weight measure-
ments taken at the ﬁrst prenatal clinic visit
(within 15 weeks’ gestation) were com-
paredwiththeself-reportedprepregnancy
weights to identify biologically implausi-
ble weight gains. Women with implausi-
ble values (n = 7) had their prepregnancy
weights imputed following previously
published methods (8). Maternal prenatal
smoking (months 1–6 of pregnancy),
household income, education, marital
status, age at conception, race/ethnicity,
pre-existing diabetes, and parity were
collected from prenatal interviews and
categorized as shown in Table 1. House-
holdincomewasexpressedaspercentage
of the poverty line and calculated using
the 2001 U.S. Department of Health
and Human Services Federal Poverty
Guidelines; a percentage #185% is the
cutoff for the Special Supplemental Nutri-
tion Program for Women, Infants, and
Children. Household income at the 3-
month postpartum interview was used
formissinginformationfromtheprenatal
period(n=7).Infantsexandbirthweight
were recorded at delivery and abstracted
fromthemedicalrecords.Gestationalage
was determined from ultrasound mea-
surements conducted before 22 weeks
gestation (up to 21 weeks, 6 days). If no
ultrasoundwas performed or if it wasnot
performed before the start of the 22nd
week then the date of the last menstrual
period was used (n =5 ) .B i r t hw e i g h tz
scores speciﬁc for infant sex and gesta-
tional age were calculated using U.S. na-
tional reference data (13).
Statistical analyses were performed
using STATA 11 (College Station, TX).
Potential effect measure modiﬁers, con-
founders, and mediators of interest were
identiﬁed a priori from a literature review
and causal diagrams (14). The interaction
of maternal glucose concentration and
prepregnancy BMI was tested in the full
models using interaction terms and Wald
tests with an a priori signiﬁcance P value
of ,0.15. Student t tests, Fisher exact
tests, and analyses of variance were used
to analyze distributions of baseline char-
acteristics. Multivariable linear regression
modelswereusedtoexamineassociations
of continuous BMI z scores with maternal
glucose concentration. Modiﬁed Poisson
regression (Poisson regression with a
robust error variance) estimated risk ra-
tios of child overweight/obesity (BMI
$85th percentile). This method has been
validated for directly estimating relative
risks for dichotomous, common outcomes
in prospective studies (15). All regression
analyses were adjusted for clustering at the
individual level (16) since there were ﬁve
women with morethanone child included
intheanalyses.The analyseswererepeated
excluding the second child of these
women,andtherewerenoappreciabledif-
ferences in the results.
RESULTS—The mean (SD) maternal
glucose concentration was 103.8 (23.7)
mg/dL.Themean(SD)prepregnancyBMI
was 24.3 (5.9) kg/m2. Approximately
30% of the women were overweight
(17.6%) or obese (12.2%). The majority
ofwomenwere25–34yearsatconception,
nonblack, married, achieved a high school
degreeorhigher,upperincome(.350%of
the 2001 Poverty Guidelines), and non-
smokers during pregnancy. Approxi-
mately half of them were nulliparous.
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tional age of the children were 3415.8
(413.4) g and 39.2 (1.2) weeks, respec-
tively. At 3 years, the mean (SD) child
BMI z score was 0.29 (0.99), 20.9% were
overweight/obese (BMI $85th percen-
tile), and 5.3% were obese (BMI $95th
percentile). Table 1 shows the distribu-
tions of selected characteristics for the
sample (n = 263) according to mean child
BMI z score. Mean child BMI z score sig-
niﬁcantly differed across categories of
maternal glucose concentration and pre-
pregnancy BMI, as well as maternal
prenatal marital status, education, and
smoking.
Table 2 displays the results from lin-
ear regression analyses for the association
ofmaternalglucoseconcentrationcatego-
ries and child BMI z score at 3 years. Each
1mg/dLincreaseinmaternalglucosecon-
centration was associated with a slight
increase in BMI z score at 3 years (esti-
mated difference in z score of 0.005,
95% CI: 20.001, 0.010, P =0 . 0 8i nt h e
adjusted model, data not shown in table).
When compared with glucose concentra-
tion ,100 mg/dL, a concentration $130
mg/dL was associated with signiﬁcantly
higher child BMI z score at 3 years in
the adjusted model (estimated difference
in z score of 0.39, 95% CI: 0.03–0.75).
We also examined the association of ma-
ternal glucose concentration categories
and risk of child overweight/obesity at
3years(Table3).Incomparisonwithglu-
coseconcentration,100mg/dL,concen-
tration $130 mg/dL was associated with
an approximate twofold greater risk of
child overweight/obesity (adjusted risk
ratio 2.34, 95% CI: 1.25–4.38). Addi-
tional adjustment of models for infant
birth weight z score did not substantially
alter any of the effect estimates. We also
did not ﬁnd an interaction between ma-
ternalglucoseconcentrationandprepreg-
nancyBMI;however,becauseof thesmall
sample size we may have lacked adequate
power to detect one if it existed.
CONCLUSIONS—With the use of
data from mother-child pairs participat-
ing in a recent, prospective, longitudinal
cohort study, we found a signiﬁcant in-
creasedriskofchildoverweight/obesityat
3 years associated with maternal glucose
concentration$130mg/dL.Theseresults
suggest that fetal exposure to high mater-
nal glucose concentration in the absence
ofpre-existingdiabetesorGDMmaycon-
tributetothe developmentofoverweight/
obesity in the offspring, independent of
maternal prepregnancy BMI.
Nearly 60 years ago, Pedersen (17)
hypothesized that fetal exposure to ma-
ternalhyperglycemiaviadiabetesresulted
in fetal hyperinsulinemia and greater ad-
iposity at birth. Since then both animal
and human studies provided evidence
to support Pedersen’so b s e r v a t i o n sa n d
increased our understanding of the path-
ophysiology of GDM (18). GDM is asso-
ciated with several adverse offspring
outcomes including macrosomia; large-
for-gestational age (LGA); respiratory dis-
tress (1); insulin resistance; and greater
risk of obesity, type 2 diabetes, and met-
abolic syndrome later in life (1). There
is adequate literature to suggest that the
associations for early infant outcomes
(macrosomia [19], LGA [12], and adipos-
ity [3]) extend to hyperglycemia during
pregnancy in the absence of pre-existing
diabetes or GDM. However, there are
fewer studies examining associations
with later childhood outcomes, speciﬁ-
cally obesity.
Consistent with the current study,
two studies found positive associations
for maternal glucose concentration and
Table 1—Baseline distributions of population characteristics according to glucose
tolerance and child BMI at 3 years in the PIN Kids Study (n = 263)
Variable N Mean BMI z score (SD) P*
Age at conception (years)
16–24 47 0.38 (0.93)
25–29 68 0.37 (1.03) 0.51
30–34 96 0.17 (0.95)
35–47 52 0.32 (1.07)
Prepregnancy BMI (kg/m
2)
Underweight (,18.5) 16 20.25 (0.65)
Normal weight (18.5–24.9) 168 0.19 (0.93) ,0.01
Overweight (25.0–29.9) 47 0.56 (0.93)
Obese ($30.0) 32 0.73 (1.28)
Maternal height (inches)
#64 107 0.23 (1.06) 0.40
.64 156 0.33 (0.95)
Race
Non-Black 238 0.27 (1.00) 0.27
Black 25 0.50 (0.96)
Marital status
Married 227 0.23 (0.99) 0.02
Other 36 0.65 (0.94)
Education
#Grade 12 32 0.49 (1.25)
Grades 13–16 126 0.40 (0.93) 0.04
$Grade 17 105 0.10 (0.95)
Family income (% 2001 poverty guidelines)
,185% 36 0.45 (0.87)
185–350% 46 0.14 (1.14) 0.37
.350% 181 0.30 (0.97)
Parity
Nulliparous 127 0.29 (0.93) 0.95
1 or more births 136 0.29 (1.05)
Smoking in months 1–6o fp r e g n a n c y
No 240 0.26 (0.97) 0.01
Yes 17 0.89 (1.17)
Infant sex
Male 142 0.37 (1.01) 0.17
Female 121 0.20 (0.97)
Glucose tolerance (mg/dL)
,100 (range 44–99) 112 0.20 (1.03)
100–,130 (range 100–129) 112 0.26 (0.94) 0.05
$130 (range 130–188) 39 0.62 (0.97)
*P values from ANOVA or Fisher exact test, testing for differences across strata.
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Maternal glucose concentration and child BMIoffspring anthropometric outcomes.
Among nondiabetic Pima Indians, Pettitt
et al. (4) showed a linear association
between maternal glucose concentration
(2-h, 75-g oral glucose tolerance test
[OGTT]) and offspring relative weights
at ages 5–24 years. There was also a
higher prevalence of obesity and higher
rates of abnormal glucose tolerance in
offspring of mothers who had abnormal
glucose tolerance during pregnancy. In
a multiethnic U.S. population, Hillier
et al. (5) reported signiﬁcant increased
odds of child BMI .85th percentile
(adjusted odds ratio [aOR]: 1.22, 95%
CI: 1.03–1.45) and BMI .95th percen-
tile (aOR: 1.28, 95% CI: 1.02–1.60) at
5–7 years associated with maternal
glucose concentration (1-h, 50-g GCT)
of 122–140 mg/dL compared with 43–
94 mg/dL.
In contrast, using data from the Bel-
fast, U.K. center of the HAPO study,
which was designed to clarify the risks of
adverse outcomes associated with various
degrees of maternal glucose intolerance
less severe than that in overt diabetes
mellitus (3), Pettitt et al. (6) found no as-
sociation between maternal glucose con-
centration (assessed using fasting glucose
and 1-h and 2-h OGTT) and child BMI
$85th and $95th percentiles at 2 years.
The only exception was a signiﬁcant in-
crease in prevalence of child BMI $85th
percentile across strata of maternal 1-h
glucose concentration. Similarly, in a
nondiabetic homogeneous Caucasian
population in Exeter, U.K. (20), despite
ﬁnding signiﬁcant correlations between
fasting plasma glucose (measured at 28
weeks’ gestation) and offspring weight,
length, and BMI at birth, none of the esti-
mates remained signiﬁcant when mea-
surements were repeated at ages 12 weeks,
1 year, and 2 years.
It has been suggested that the effects
of maternal glucose concentration are
long term and differ depending on the
age of the offspring (6). For example,
when comparing offspring of women
with and without GDM, there are signiﬁ-
cant differences in weight at birth, which
are not apparent at 1.5 years but then re-
cur later in childhood at 7.7 years (21). In
thisstudy,childrenwere;3years,which
is younger than the ages of the popula-
tions used in studies that reported posi-
tive associations (4,5) but older than
those used in studies reporting null ﬁnd-
ings(6,20).Our resultsadd tothecurrent
evidence suggesting that the effects of fe-
tal glucose exposure on the development
of child overweight/obesity are apparent
at later ages. However, there is a lack of
consistencyacrossstudiesinmethodology
concerning maternal glucose concentra-
tion measurements, study populations,
as well as adjustment for potential con-
founding variables, which makes it dif-
ﬁcult to compare results. More research
is necessary to understand the inﬂuence
of maternal glucose concentration on
offspring anthropometric development
among women without diabetes.
There are several limitations of the
current study that must be considered
when interpreting the results. A main
limitationisthelosstofollow-upbetween
birth and 3 years that resulted in a dis-
proportionate loss of women from high
risk groups and likely weakened the
observed associations. Additionally, the
loss in sample size may have diminished
the power necessary to detect some as-
sociations and interactions, if they existed.
The generalizability of our sample may
be limited because women were mostly
white, well educated, and upper income,
resulting in a lower prevalence of over-
weight and obesity compared with na-
tionalestimatesforwomenofreproductive
ages (22).
Other limitations are due to our
measurements of maternal glucose con-
centration and child anthropometrics. A
standard cut-point of 140 mg/dL deﬁned
anabnormalvalueontheuniversalscreen
and resulted in further testing for GDM;
however, a cut-point of 130 mg/dL is
more sensitive and may be considered a
better diagnostic tool for GDM (23).
Therefore, some of the women with GCT
values $130 mg/dL but ,140 mg/dL (n =
20) may have been missed as GDM cases
and included in our analyses. This type of
misclassiﬁcation would likely strengthen
the observed effect estimates, especially if
these women remained untreated. Child
Table 3—Risk ratios for maternal glucose concentration and child BMI ‡85th percentile at 3 years in the PIN Study
Model 1* (n = 263) Model 2† (n = 256) Model 3‡ (n = 254)
Risk ratio (95% CI) P Risk ratio (95% CI) P Risk ratio (95% CI) P
Glucose concentration (per mg/dL) 1.01 (1.00–1.02) 0.15 1.01 (1.00–1.02) 0.08 1.01 (1.00–1.02) 0.11
,100 mg/dL Reference Reference Reference
100–,130 mg/dL 1.00 (0.56–1.78) 1.00 1.04 (0.60–1.81) 0.88 0.98 (0.56–1.71) 0.94
$130 mg/dL 2.15 (1.21–3.84) 0.01 2.34 (1.25–4.38) 0.01 2.48 (1.27–4.82) 0.01
Risk ratios for maternal glucose concentration are per mg/dL and categories. *Model 1: unadjusted. †Model 2: adjusted for maternal education, race, prenatal
smoking, prepregnancy BMI, and maternal height. ‡Model 3: adjusted for Model 2 and birth weight z score.
Table 2—Estimated differences in child BMI z score at 3 years associated with categories of maternal glucose concentration
in the PIN Kids Study
Glucose concentration
Model 1† (n = 263) Model 2‡ (n = 256) Model 3§ (n =2 5 4 )
b*( 9 5 %C I ) P b (95% CI) P b (95% CI) P
,100 mg/dL Reference Reference Reference
100–,130 mg/dL 0.05 (20.21–0.31) 0.70 0.07 (20.18–0.32) 0.59 0.01 (20.24–0.26) 0.93
$130 mg/dL 0.44 (0.08–0.80) 0.02 0.39 (0.03–0.75) 0.03 0.39 (0.02–0.75) 0.04
*Coefﬁcient from linear regression analysis. †Model 1: unadjusted. ‡Model 2: adjusted for maternal education, race, prenatal smoking, prepregnancy BMI, and
maternal height. §Model 3: adjusted for Model 2 and birth weight z score.
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posity but it is correlated (r = 0.75) with
percentbodyfatinchildrenaged3–8ye ar s
(24). Finally, it is likely that the observed
associations between maternal glucose
concentration and child BMI partly reﬂect
the effects of genetic or environmental
factors (such as child diet and physical ac-
tivity) related to a woman’s glucose con-
centration and health behaviors in the
postnatal period, which we were unable
to consider in our etiologic model.
The results from this study suggest
that high maternal glucose concentration
($130 mg/dL) in the absence of a pre-
existing diabetes or GDM diagnosis is a
modiﬁable and preventable behavioral
factor associated with offspring over-
weight/obesity at 3 years. Prenatal inter-
vention efforts may consider monitoring
womenwhomeetsuchcriteriaasawayto
decrease fetal exposure to high maternal
glucose concentration and possibly pre-
vent excess weight development. Future
studies, such as the HAPO study (2), that
collect longitudinal data before preg-
nancy through late childhood, including
comprehensivemeasuresofmaternalglu-
cose concentration, child adiposity, and
potential confounders, are needed.
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